---
title: Ajinomoto Bio-Pharma Services vs Neuland Laboratories
slug_a: ajibio-pharma
slug_b: neulandlabs
site: cdmo
review_signal_gate: closed
canonical_path: /compare/ajibio-pharma/neulandlabs
---

# Ajinomoto Bio-Pharma Services vs Neuland Laboratories

Side-by-side profile data from each company listing on this directory.

## Ajinomoto Bio-Pharma Services

- Profile: [/companies/ajibio-pharma](/companies/ajibio-pharma)

Ajinomoto Bio-Pharma Services — Ajinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service.

Services: 8. Modalities: 6. Indications: 0. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Small Molecule Development & Manufacturing
- Biologics Development & Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Process Development
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Small Molecule
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- Gene Therapy
- Peptide

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## Neuland Laboratories

- Profile: [/companies/neulandlabs](/companies/neulandlabs)

Neuland Laboratories — Global API CDMO supporting biotechnology and pharmaceutical companies in design, development, and manufacturing of complex active pharmaceutical ingredients from early-stage drug development through commercial scale.

Services: 7. Modalities: 2. Indications: 0. Locations: 5. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- API Synthesis & Manufacturing
- Peptide Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Peptide

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Commercial (>100 kg / tonne)